AMRX vs FVRR · P/E 44, rev $1.52B vs P/E 13, rev $430.9M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Fiverr International Ltd (FVRR) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Fiverr International Ltd (FVRR) is a internet content & information company listed on US.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported FVRR revenue for 2025-12-31 was $430.9M. Net income was $21.0M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. FVRR currently screens at market cap $368.1M and trailing P/E 13.3.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. FVRR currently screens at market cap $368.1M and trailing P/E 13.3.
Not investment advice. Open the AMRX and FVRR stock pages for the full models.
Not investment advice.